Autres langues Alkem Laboratories Limited Bombay S.E.

Actions

ALKEM

INE540L01014

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:50 03/05/2024			Varia. 5j.	Varia. 1 janv.
4 899 ^INR	+2,36%		-0,04%	-5,65%

28/03	Alkem Laboratories crée une filiale pour ses activités dans le domaine des dispositifs médicaux	MT
28/03	Alkem Laboratories Limited annonce la création d'une filiale, Alkem Medtech Private Limited	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak	16/04
Alkem Laboratories Forms Subsidiary for Medical Devices Business	28/03
Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited	28/03
Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection	28/03
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy	12/02
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	12/02
Alkem Laboratories Limited Approves Interim Dividend for Financial Year 2023-24 , Payable on 1 March, 2024	09/02
Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Research Update Biosergen: Licensing deal with Alkem and CTA submission	16/01
Indian Equities Close Higher on Friday, Lifted by IT Stocks	12/01
Alkem Laboratories Names Successor to Outgoing CFO	12/01
Alkem Laboratories Limited Announces CFO Changes	12/01
Heritage Global, Investors Acquire Pharmaceutical Plant from Alkem Laboratories	11/01
Federal Machinery & Equipment Co., Heritage Global Partners, Inc., New Mill Capital LLC, Keith Machinery Corp acquired Pharmaceutical Site in Fenton Missouri from Alkem Laboratories Limited.	11/01
Alkem Laboratories Limited Appoints Ashish Sehgal to Hold Senior Management Position in the Company Effective 15 December 2023	15/12
Biosergen's Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy	12/12
Alkem Laboratories Limited Submits Clinical Trial Application to Central Drugs Standard Control Organization in India	12/12
Alkem Laboratories Limited Submits Clinical Trial Application for First Patient Study with Bsg005 in Invasive Fungal Infections in India as A Rescue Therapy	12/12
Biosergen's Indian Partner Seeks Approval for Clinical Trial of Antifungal Drug Candidate	12/12
Alkem Laboratories Limited Appoints Kaustav Banerjee to Hold Senior Management Position	05/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Alkem Laboratories Limited Bombay S.E.

Actions

ALKEM

INE540L01014

Autres langues

Filtres